Drug Trial Radar · NCT07843329
A Trial to See if Daridorexant Can Help Adults and Elderly People With Insomnia Sleep Better During the Night and Function Better During the Day
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
344
Planned (sponsor's estimate)
Start
Oct 28, 2026
Primary completion
Nov 22, 2027
Study completion Dec 6, 2027
Sponsor
- Lead sponsor
- Idorsia Pharmaceuticals Ltd.Industry
- Sponsor type
- Industry
- First posted
- Sep 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial is to collect more data about the effect of daridorexant in adults and elderly people with insomnia disorder. The trial aims to find out whether daridorexant can help improve: * how trial participants sleep at night, * how trial participants function the next day. Researchers will compare daridorexant to a placebo (a look-alike inactive substance that contains no active medicine) to understand which effect daridorexant has on total sleep time and next-day functioning. Enrolled participants will: * Take daridorexant 50 mg or placebo once daily for approximately 3 months * Visit the clinic once every month during treatment for checkups and tests * Keep a sleep diary of the number of hours they sleep and how well they sleep * Complete a questionnaire every day about any symptoms of sleepiness during the day and any impact on physical and mental functioning such as energy levels, mood, or ability to concentrate or memorize.
Conditions
- Insomia Disorder
Interventions
DaridorexantDrug
Daridorexant 50 mg tablets
PlaceboDrug
Matching placebo tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline to Month 3 in Subjective Total Sleep Time (sTST)Time frame: Baseline and Month 3
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Preferred Research Partners Inc.
Little Rock, Arkansas · Not yet recruiting
Synergy San Diego
Lemon Grove, California · Not yet recruiting
Empire Clinical Research
Pomona, California · Not yet recruiting
Teradan Clinical Trials, LLC
Brandon, Florida · Not yet recruiting
Hope Research Network
Virginia Gardens, Florida · Recruiting
Encore Medical Research, LLC - Weston
Weston, Florida · Not yet recruiting
Advanced Respiratory and Sleep Medicince LLC
Huntersville, North Carolina · Not yet recruiting
Eximia Research - NC, LLC
Raleigh, North Carolina · Not yet recruiting
CTI Clinical Research Center
Cincinnati, Ohio · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.